Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018

• Main Authors: Paolo Gaibani (Author), Donatella Lombardo (Author), Linda Bussini (Author), Federica Bovo (Author), Beatrice Munari (Author), Maddalena Giannella (Author), Michele Bartoletti (Author), Pierluigi Viale (Author), Tiziana Lazzarotto (Author), Simone Ambretti (Author)
• Format: Book
• Published: MDPI AG, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Meropenem/Vaborbactam (MEM-VAB) is a novel carbapenem- β-lactamase inhibitor active against KPC-producing Enterobacteria. Herein, we evaluate the incidence of meropenem/vaborbactam-resistance among KPC-producing <i>K. pneumoniae</i> (KPC-Kp) bloodstream infection in a large Italian hospi...